Technology ID
TAB-4614
Novel Small Molecule Inhibitors of Ebola Virus
E-Numbers
E-018-2019-0
Lead Inventor
Flint, Michael
Lead IC
CDC
Co-Inventors
Spiropoulou, Christina
Amblard, Frank
Schinazi, Raymond
Lo, Michael
ICs
CDC
Applications
Vaccines
Therapeutics
Research Materials
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
This technology includes a compound, CDEU050, which has shown to have anti-Ebola virus activity in cell culture. CDEU050 is a novel small molecule, unrelated to any previously described inhibitor that blocks Ebola virus infection in cell culture.
Commercial Applications
Development of a clinical candidate for Ebola virus.
Competitive Advantages
There are no therapeutics or vaccines approved to protect from infection with Ebola virus.
Licensing Contact: